1. Introduction {#sec1-ijerph-15-01769}
===============

According to the guideline for trauma patients from Advanced Trauma Life Support (ATLS), hypothermia, normothermia, and hyperthermia were defined as body temperatures of \<36 °C, between 36 °C and 38 °C, and \>38.1 °C, respectively, upon arrival to the emergency department (ED). In trauma patients, hypothermia, acidosis, and coagulopathy have been referred to as the lethal triad \[[@B1-ijerph-15-01769]\] that leads to a worse patient outcome. Increased mortality rates varying from 5.5% to 53.9% and even up to 100% have been reported in trauma patients with sustained hypothermia \[[@B2-ijerph-15-01769],[@B3-ijerph-15-01769],[@B4-ijerph-15-01769],[@B5-ijerph-15-01769],[@B6-ijerph-15-01769],[@B7-ijerph-15-01769],[@B8-ijerph-15-01769],[@B9-ijerph-15-01769],[@B10-ijerph-15-01769],[@B11-ijerph-15-01769],[@B12-ijerph-15-01769],[@B13-ijerph-15-01769],[@B14-ijerph-15-01769],[@B15-ijerph-15-01769]\]. The etiology of hypothermia in trauma patients, including sedation, alcohol intoxication, fluid resuscitation, blood transfusion, and shock, seems to be multifactorial and interdependent \[[@B16-ijerph-15-01769]\]. Recent studies reported hypothermia to be associated with an increased injury severity \[[@B17-ijerph-15-01769]\] and a predictor of mortality in trauma patients \[[@B2-ijerph-15-01769],[@B3-ijerph-15-01769],[@B4-ijerph-15-01769],[@B5-ijerph-15-01769],[@B6-ijerph-15-01769],[@B7-ijerph-15-01769],[@B8-ijerph-15-01769],[@B9-ijerph-15-01769],[@B10-ijerph-15-01769],[@B11-ijerph-15-01769]\]. However, there is controversy regarding the relationship between hypothermia and mortality outcomes, with potential confounders such as age, sex, preexisting comorbidities, shock, and injury severity. The definition of hypothermia may, however, significantly affect the observed clinical outcomes. To solve these limitations, a well-designed randomized controlled trial is needed, although it is difficult to perform in trauma patients. As an alternative, propensity score matching (PSM) is a methodology used to control for sample selection bias and to simulate the randomization process. This study aimed to assess whether hypothermia is an independent predictor of mortality in trauma patients in the condition of defining hypothermia as body temperatures of \<36 °C. To achieve this study goal, the present study used a PSM model to determine the effect of hypothermia defined by ATLS on in-hospital mortality of trauma patients, and to estimate the effect of body temperature on in-hospital mortality by using multivariate logistic regression.

2. Methods {#sec2-ijerph-15-01769}
==========

2.1. Study Design, Definitions, and Patient Selection {#sec2dot1-ijerph-15-01769}
-----------------------------------------------------

After receiving approval from the institutional review board of the Chang Gung Memorial Hospital (number 201700012B0), a retrospective review of the Trauma Registry System at a level I trauma center of the Kaohsiung Chang Gung Memorial Hospital \[[@B18-ijerph-15-01769],[@B19-ijerph-15-01769]\] was performed to identify all adult trauma patients admitted via the ED from 1 January 2009 to 12 December 2015. The inclusion criteria consisted of patients aged at least 20 years and hospitalized for all trauma causes. The exclusion criteria included patients with missing information, such as vital signs or Glasgow Coma Scale (GCS) score; those who were dead on arrival; those who died in the ED; or those who were discharged from the ED. Patients with hyperthermia were not included. Based on their temperature upon arrival to the ED, the study population was finally divided to those displaying hypothermia (body temperatures of \<36 °C) and those with normothermia (body temperatures between 36 °C and 38 °C) groups.

2.2. Clinical Parameters and Outcome Evaluation {#sec2dot2-ijerph-15-01769}
-----------------------------------------------

Data retrieved from the two study groups included gender; sex; comorbidities; mechanisms of injury; vital signs and GCS on ED; laboratory data in the ED, which included the blood alcohol concentration (BAC), hemoglobin (Hb), hematocrit (Hct), prothrombin time (PT), and activated partial thromboplastin time (aPTT); abbreviated injury scale (AIS) score, injury severity score (ISS), hospital length of stay (LOS); rate of ICU admission; and in-hospital mortality. The primary outcome was in-hospital mortality.

2.3. Statistical Analysis {#sec2dot3-ijerph-15-01769}
-------------------------

IBM SPSS Statistics for Windows, version 22.0 (IBM Corp., Armonk, NY, USA) was used to perform all descriptive and comparative statistics. We first compared the unadjusted variables between the hypothermia and normothermia groups. Demographic and clinical characteristics were analyzed using chi-square tests for categorical variables presented as odds ratios (ORs) with 95% confidence intervals (CIs) and analysis of variance tests for continuous variables. A multivariate logistic regression analysis was performed in order to identify factors related to mortality. Pearson correlation was used to determine if correlations were present between the biochemistry of Hb, Hct, PT, and aPTT levels and the body temperature of the trauma patients. To account for the nonrandom assignment of patients between the two groups, PSM analysis was employed to reduce the potential selection bias. The potential confounders adjusted in the PSM included age, sex, preexisting comorbidities, and ISS. After 1:1 matching with propensity scores calculated with logistic regression analysis with the aforementioned confounding factors, the patient outcomes were analyzed by conditional Cox proportional hazard regression. For this study, *p* values of \<0.05 were considered to indicate statistical significance.

3. Results {#sec3-ijerph-15-01769}
==========

3.1. Demographic Data and Clinical Characteristics of the Study Population {#sec3dot1-ijerph-15-01769}
--------------------------------------------------------------------------

Of 23,705 enrolled patients, 401 hypothermic patients and 13,368 normothermic patients ([Figure 1](#ijerph-15-01769-f001){ref-type="fig"}) were included in the analysis after filtering. Only 3.0% of patients had hypothermia upon arrival to the ED. As shown in [Table 1](#ijerph-15-01769-t001){ref-type="table"}, a significantly higher proportion of hypothermic patients were male (64.8% vs. 55.8%; *p* \< 0.001). There was no significant difference in age and comorbidities between the hypothermia and normothermia groups, except that the incidence of hypertension was significantly higher in the normothermic patients. Hypothermic patients presented with a significantly higher incidence of alcohol intoxication, defined as a BAC of ≥50 mg/dL. Hypothermic patients also presented with a significantly lower systolic blood pressure (SBP) and a higher incidence of low SBP, defined either as SBP of ≤60 or 90 mmHg. There was no significant difference in heart or respiratory rates between hypothermic patients and normothermic patients. Regarding trauma mechanisms, more hypothermic patients were injured as the driver of a motor vehicle, the driver of a motorcycle, and as a victim in a strike injury, but less were injured in a fall compared to normothermic patients. Compared to normothermic patients, hypothermic patients had a significantly lower GCS score; higher rate of AIS score of ≥3 in the head/neck, thorax, and abdomen; a lower rate of AIS score of ≥3 in the extremities; and a higher ISS. The distribution of ISS according to the ISS stratification (\<16, 16--24, and ≥25) revealed that more hypothermic patients had an ISS of 16--24 and ≥25 and fewer had an ISS of \<16 compared to normothermic patients. The mortality rate in hypothermic patients was significantly higher than that in normothermic patients (13.5% vs. 2.3%, OR: 6.6, 95% CI: 4.86--9.01, *p* \< 0.001). Hospital LOS was also significantly longer for hypothermic patients than for normothermic patients (12.4 days vs. 10.1 days, *p* = 0.001) and significantly more hypothermic patients were admitted to the ICU than were normothermic patients (43.6% vs. 21.4%, OR: 2.8, 95% CI: 2.33--3.48, *p* \< 0.001). Regarding hematologic biochemistry parameters ([Table 2](#ijerph-15-01769-t002){ref-type="table"}), hypothermic patients had significantly lower hemoglobin and hematocrit levels and impaired coagulation function, as indicated by PT and aPTT, than normothermic patients (PT, 11.7 ± 4.7 vs. 10.9 ± 2.6; *p* \< 0.001; aPTT, 29.6 ± 12.0 vs. 27.3 ± 4.4; *p* \< 0.001). As shown in [Table 3](#ijerph-15-01769-t003){ref-type="table"} and [Figure 2](#ijerph-15-01769-f002){ref-type="fig"}, the Pearson correlation revealed that body temperature was negatively correlated with PT (correlation coefficient = −0.035, *p* \< 0.001) and aPTT (correlation coefficient = −0.068, *p* \< 0.001); however, these correlations were very weak. In addition, no significant correlation of body temperature to the level of Hb and Hct was found.

3.2. Risk Factors Associated with Mortality {#sec3dot2-ijerph-15-01769}
-------------------------------------------

As shown in [Table 4](#ijerph-15-01769-t004){ref-type="table"}, in the comparison between fatal and survival patients, the fatal patients were predominantly male, significantly older, and had higher rates of pre-existed CAD, CHF, and ESRD than those of survival patients. In addition, the fatal patients presented a significantly lower temperature, SBP, and HR, but higher ISS, than that of those survival patients. Multivariate logistic regression analysis ([Table 5](#ijerph-15-01769-t005){ref-type="table"}) revealed that patients being male, with older age, pre-existed CHF and ESRD, low body temperature, and with a higher injury severity were significantly associated with the mortality outcome.

3.3. Outcomes of the PSM Study Population {#sec3dot3-ijerph-15-01769}
-----------------------------------------

Propensity score-matched patients were selected to reduce the effect of differences in sex and age, preexisting comorbidities, and injury severity of the patient population on the outcome assessment. The 399 well-balanced pairs did not have significant differences in sex, age, co-morbidity, or ISS ([Table 6](#ijerph-15-01769-t006){ref-type="table"}). There were no significant differences between these two propensity score-matched study populations regarding mortality, hospital LOS, ICU admission rates, and PT and aPTT levels. Although the mortality rate remained higher in hypothermic patients, the risk of this outcome was not statistically significant (13.0% vs. 9.3%, OR: 1.5, 95% CI: 0.94--2.29, *p* = 0.115).

4. Discussion {#sec4-ijerph-15-01769}
=============

In this study, the unadjusted analysis suggested a significant association between hypothermia and mortality and multivariate logistic regression analysis revealed that patients' low body temperature was significantly associated with the mortality outcome. However, PSM analysis in the propensity score-matched study populations with minimized potential confounding factors did not identify that hypothermia defined by the body temperatures of \<36 °C was associated with increased mortality, longer hospital LOS, or ICU admission rate. These contradicting observations indicated the limitation of the traditional definition of body temperature for the diagnosis of hypothermia with a cut off at 36 °C. Without the consideration of depth of hypothermia, the mechanism that led to the hypothermia, or the rate of decline of core body temperature, the division of the trauma patients into hypothermia or normothermia according a defined body temperature is too simple for the prediction of the outcome from injury. The conflict in the observed results also reflect the current diverse opinions regarding the association of hypothermia and mortality. Most of the retrospective and prospective studies found that hypothermia is not only an ominous sign but also an independent predictor of mortality \[[@B2-ijerph-15-01769],[@B3-ijerph-15-01769],[@B4-ijerph-15-01769],[@B5-ijerph-15-01769],[@B6-ijerph-15-01769],[@B7-ijerph-15-01769],[@B8-ijerph-15-01769],[@B9-ijerph-15-01769],[@B10-ijerph-15-01769],[@B11-ijerph-15-01769]\]. In contrast, Trentzsch et al. \[[@B15-ijerph-15-01769]\] analyzed 5197 trauma patients and concluded that hypothermia is just an after effect of blood loss and hemorrhagic shock and thus a result of injury severity, which is unlikely to be an independent predictor of mortality. Mommsen et al. \[[@B14-ijerph-15-01769]\] failed to prove that accidental hypothermia was an independent factor for mortality in the multivariate analysis. In addition, after correcting for injury severity, including physiologic and anatomic indicators, a retrospective study by Steinemann et al. \[[@B13-ijerph-15-01769]\] reported no difference in mortality rates between hypothermic and normothermic patients. Furthermore, a prospective observational study of trauma patients found that a body temperature of \<35 °C was a significant risk factor for multiple organ dysfunction, but that early hypothermia was not an independent predictor of mortality \[[@B12-ijerph-15-01769]\].

Obviously, the differences in cut-off points for hypothermia and population characteristics would lead to diverse or even contracting observations of the outcomes. Hypothermic patients generally had higher injury severity and incidence of lower blood pressure than those in normothermic patients. Furthermore, hypothermic patients more often had severe injuries to the head, chest, and abdomen compared to normothermic patients. Therefore, it is not surprising that the vital signs of these patients were often unstable. In this study, although the injury severity had been adjusted in PSM to estimate the effect of hypothermia on mortality, it should be noted that, with the continuous variable of body temperatures being turned into a binary categorical data, the cut-off value selected for a definition of hypothermia (i.e., body temperatures of \<36 °C in this study) may present a bias or even a false negative finding in the outcome measurement. For example, a much lower temperature (e.g., 32 °C or less) may even present a survival advantage for the trauma patients, as evidenced by a decreased odds ratio for death in the therapeutic hypothermia \[[@B20-ijerph-15-01769],[@B21-ijerph-15-01769],[@B22-ijerph-15-01769]\]. Furthermore, Reynolds et al. reported that a temperature of \<34 °C in hemorrhagic patients requiring massive transfusion was associated with a two-fold increased risk of mortality \[[@B11-ijerph-15-01769]\]. Klauke et al. and Waibel et al. defined hypothermia as a core body temperature of \<36 °C \[[@B3-ijerph-15-01769],[@B5-ijerph-15-01769]\], whereas other studies defined hypothermia as a core body temperature of \<35 °C \[[@B6-ijerph-15-01769],[@B8-ijerph-15-01769]\]. Our current study observed hypothermia, defined as a temperature of \<36 °C, in 3.0% of patients, with a 13.5% mortality rate for hypothermic patients. Our incidence was less than the previously reported incidences of 15.7--22.9% in which hypothermia was similarly defined as \<36 °C \[[@B3-ijerph-15-01769],[@B5-ijerph-15-01769]\]. The lower incidence of hypothermia may be attributed to the location of our institution in southern Taiwan, which has a subtropical climate with less chance of hypothermia exposure \[[@B23-ijerph-15-01769],[@B24-ijerph-15-01769]\], as well as the convenient access that decreases the pre-hospital time to care. However, the mortality rate of hypothermic patients in this study was similar to that reported in previous studies, which ranged from 7.4% to 14.6% \[[@B3-ijerph-15-01769],[@B5-ijerph-15-01769]\].

Hypothermia-induced coagulopathy is of potential physiological concern. Although coagulopathy is a member of the lethal triad \[[@B1-ijerph-15-01769]\], significant coagulopathy does not develop until below 34 °C. Moreover, hypothermia coagulopathy occurs even at a high core temperature and reversible platelet dysfunction occurs during hypothermia, which is the probable source of dysfunctional bleeding noted with hypothermia \[[@B25-ijerph-15-01769]\]. A study on the impact of hypothermia on platelet function in a porcine model of multiple trauma reported that mild hypothermia affects the coagulation system but does not aggravate trauma-induced coagulopathy \[[@B26-ijerph-15-01769]\]. In this study, the Pearson correlation revealed that the body temperature was negatively correlated with PT and aPTT; however, these correlations are very weak. The propensity score-matched hypothermic patients also did not present significant coagulopathy compared to normothermic patients. However, this observation may also be limited by the traditional definition of body temperature for the diagnosis of hypothermia.

Although the incidence of hypothermia at the time of admission varies between 1.57% and 44.6% in trauma patients \[[@B2-ijerph-15-01769],[@B3-ijerph-15-01769],[@B4-ijerph-15-01769],[@B5-ijerph-15-01769],[@B6-ijerph-15-01769],[@B7-ijerph-15-01769],[@B8-ijerph-15-01769],[@B9-ijerph-15-01769],[@B10-ijerph-15-01769],[@B11-ijerph-15-01769],[@B12-ijerph-15-01769],[@B13-ijerph-15-01769],[@B14-ijerph-15-01769],[@B15-ijerph-15-01769]\], attending physicians may fail to identify hypothermia in the ED. In a retrospective analysis of the association between hypothermia on admission and clinical outcomes in 58,947 major trauma patients, 8.8% of patients were excluded due to temperature not being recorded \[[@B7-ijerph-15-01769]\]. In a retrospective analysis of 642 trauma admissions in a trauma center, up to 33% of patients had no temperature recorded in the ED \[[@B27-ijerph-15-01769]\]. The effect of hypothermia may even be overlooked in regions with tropical or subtropical climates, such as in Taiwan, where the risk of low temperature exposure is relatively low. This study presented, with contrasting results, an unsolved problem regarding the impact of admission body temperature on the trauma patients. Prospective randomized control trials are needed to determine the relationship between hypothermia following trauma and the clinical outcome.

This study had several other limitations. First, the retrospective design and the use of data retrieved from a single center resulted in an inherent bias. Second, potential confounders (e.g., infused fluid volume and temperature, blood transfusion, ventilator use, time interval from the initial scene to the ED, and resuscitation during the transportation to the ED) were not controlled for in this study and may have led to a selection bias. Finally, patients declared dead at the scene of an accident or upon hospital arrival were not included in the database, which may have led to a selection bias.

5. Conclusions {#sec5-ijerph-15-01769}
==============

This study revealed that low body temperature was associated with the mortality outcome in the multivariate logistic regression analysis but not in the PSM model that compared patients with hypothermia defined as body temperatures of \<36 °C to those who had normothermia. These contradicting observations indicated that there is limitation for the diagnosis of hypothermia according to the traditional definition of body temperature. Prospective randomized control trials are needed to determine the relationship between hypothermia following trauma and the clinical outcome.
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ijerph-15-01769-t001_Table 1

###### 

Demographics and admission characteristics of the study groups.

  -----------------------------------------------------------------------------------------------------------------
  Variables                 Hypothermia\   Normothermia\   Odds Ratio\   *p*                              
                            *n* = 401      *n* = 13,368    (95% CI)                                       
  ------------------------- -------------- --------------- ------------- --------- ------ --------------- ---------
  Sex, *n* (%)                                                                                            \<0.001

  Male                      260            (64.8)          7455          (55.8)    1.5    (1.19--1.80)    

  Female                    141            (35.2)          5913          (44.2)    0.7    (0.56--0.84)    

  Age (years)               53.3           ±19.0           54.3          ±19.4     ---    0.293           

  Comorbidity, *n* (%)                                                                                    

  HTN                       99             (24.7)          3972          (29.7)    0.8    (0.62--0.98)    0.030

  DM                        59             (14.7)          2119          (15.9)    0.9    (0.69--1.21)    0.579

  CVA                       13             (3.2)           589           (4.4)     0.7    (0.42--1.27)    0.270

  CAD                       16             (4.0)           554           (4.1)     1.0    (0.58--1.60)    0.901

  CHF                       5              (1.2)           125           (0.9)     1.3    (0.54--3.29)    0.594

  ESRD                      11             (2.7)           288           (2.2)     1.3    (0.70--2.36)    0.484

  BAC ≥ 50 mg/dL, *n* (%)   60             (15.0)          871           (6.5)     2.5    (1.90--3.35)    \<0.001

  Alcohol level (mg/dL)     213.0          ±90.4           187.1         ±73.3     ---    0.010           

  SBP (mmHg)                137.8          ±46.0           151.4         ±34.2     ---    \<0.001         

  SBP ≤ 60 mmHg, *n* (%)    18             (4.5)           45            (0.3)     13.9   (7.98--24.26)   \<0.001

  SBP ≤ 90 mmHg, *n* (%)    46             (11.5)          307           (2.3)     5.5    (3.97--7.65)    \<0.001

  HR (beats/min)            83.9           ±26.4           86.3          ±17.4     ---    0.109           

  RR (times/min)            18.7           ±5.0            18.6          ±2.0      ---    0.741           

  Mechanism, *n* (%)                                                                                      

  Driver of MV              16             (4.0)           224           (1.7)     2.4    (1.45--4.09)    0.002

  Passenger of MV           5              (1.2)           97            (0.7)     1.7    (0.70--4.27)    0.225

  Driver of motorcycle      195            (48.6)          5380          (40.2)    1.4    (1.15--1.72)    \<0.001

  Passenger of motorcycle   4              (1.0)           270           (2.0)     0.5    (0.18--1.32)    0.200

  Bicyclist                 18             (4.5)           506           (3.8)     1.2    (0.74--1.93)    0.506

  Pedestrian                7              (1.7)           277           (2.1)     0.8    (0.39--1.79)    0.727

  Fall                      96             (23.9)          4611          (34.5)    0.6    (0.47--0.75)    \<0.001

  Penetrating injury        11             (2.7)           563           (4.2)     0.6    (0.35--1.18)    0.163

  Blunt injury              28             (7.0)           1168          (8.7)     0.8    (0.53--1.16)    0.242

  Strike by/against         21             (5.2)           272           (2.0)     2.7    (1.69--4.20)    \<0.001

  GCS                       12.2           ±4.5            14.2          ±2.3      ---    \<0.001         

  ≤8                        89             (22.2)          688           (5.1)     5.3    (4.10--6.74)    \<0.001

  9--12                     29             (7.2)           551           (4.7)     1.8    (1.23--2.67)    0.003

  ≥13                       283            (70.6)          12,129        (90.1)    0.2    (0.20--0.31)    \<0.001

  AIS ≥ 3                                                                                                 

  Head/neck                 154            (38.4)          2728          (20.4)    2.4    (1.98--2.99)    \<0.001

  Face                      1              (0.2)           33            (0.2)     1.0    (0.14--7.41)    1.000

  Thorax                    50             (12.5)          855           (6.4)     2.1    (1.54--2.83)    \<0.001

  Abdomen                   18             (4.5)           339           (2.5)     1.8    (1.11--2.93)    0.019

  Extremity                 105            (26.2)          4321          (32.3)    0.7    (0.59--0.93)    0.011

  ISS (median, IQR)         10             (5--20)         9             (4--10)   ---    \<0.001         

  \<16                      236            (58.9)          10,929        (81.8)    0.3    (0.26--0.39)    \<0.001

  16--24                    86             (21.4)          1712          (12.8)    1.9    (1.46--2.37)    \<0.001

  ≥25                       79             (19.7)          727           (5.4)     4.3    (3.30--5.52)    \<0.001

  Mortality, *n* (%)        54             (13.5)          307           (2.3)     6.6    (4.86--9.01)    \<0.001

  Hospital LOS (days)       12.4           ±12.9           10.1          ±10.8     ---    0.001           

  ICU admission, *n* (%)    175            (43.6)          2858          (21.4)    2.8    (2.33--3.48)    \<0.001
  -----------------------------------------------------------------------------------------------------------------

Data are presented as means ± SD, median (IQR), or *n* (%). HTN, hypertension; DM, diabetic mellitus; CVA, cerebral vascular accident; CAD, coronary artery disease; CHF, congestive heart failure; ESRD, end-stage renal disease; BAC, blood alcohol concentration; SBP, systolic blood pressure; HR, heart rate; RR, respiratory rate; MV, motor vehicle; GCS, Glasgow coma score; AIS, abbreviated injury scale; ISS, injury severity scale; LOS, length of stay; ICU, intensive care unit.

ijerph-15-01769-t002_Table 2

###### 

Comparison of biochemistry between study groups.

  ------------------------------------------------------------------------------------------------------------
  Variables           Hypothermia *n* = 401   Normothermia *n* = 13,368   Odds Ratio\   *p*          
                                                                          (95% CI)                   
  ------------------- ----------------------- --------------------------- ------------- ------ ----- ---------
  Hemoglobin (g/dL)   12.8                    ±2.5                        13.1          ±2.1   ---   0.016

  Hematocrit (%)      38.0                    ±6.9                        38.8          ±6.4   ---   0.022

  PT (seconds)        11.7                    ±4.7                        10.9          ±2.6   ---   \<0.001

  aPTT (seconds)      29.6                    ±12.0                       27.3          ±4.4   ---   \<0.001
  ------------------------------------------------------------------------------------------------------------

Data are presented as means ± SD. PT, prothrombin time; aPTT, activated partial thromboplastic time.

ijerph-15-01769-t003_Table 3

###### 

Correlation of biochemistry to temperature in study population.

  Variables           Pearson Correlation   *p*
  ------------------- --------------------- ---------
  Hemoglobin (g/dL)   −0.011                0.067
  Hematocrit (%)      −0.016                0.067
  PT (seconds)        −0.035                \<0.001
  aPTT (seconds)      −0.068                \<0.001

PT, prothrombin time; aPTT, activated partial thromboplastic time.

ijerph-15-01769-t004_Table 4

###### 

Comparison of variable between fatal and survival patient groups.

  Variables               Mortality *n* = 361   Survival *n* = 13,408   *p*               
  ----------------------- --------------------- ----------------------- ------- --------- ---------
  Gender, *n* (%)                                                                         \<0.001
  Male                    241                   (66.8)                  7474    (55.7)    
  Female                  120                   (33.2)                  5934    (44.3)    
  Age (years)             60.4                  ±19.7                   54.1    ±19.3     \<0.001
  Co-morbidity, *n* (%)                                                                   
  HTN                     118                   (32.7)                  3953    (29.5)    0.198
  DM                      61                    (16.9)                  2117    (15.8)    0.609
  CVA                     22                    (6.1)                   580     (4.3)     0.116
  CAD                     26                    (7.2)                   544     (4.1)     0.005
  CHF                     8                     (2.2)                   122     (0.9)     0.021
  ESRD                    22                    (6.1)                   277     (2.1)     \<0.001
  Temperature (°C)        36.0                  ±2.8                    36.5    ±0.6      0.002
  SBP (mmHg)              144.6                 ±57.0                   151.2   ±33.8     0.029
  HR (beats/min)          47.8                  ±35.0                   65.5    ±29.4     \<0.001
  RR (times/min)          18.5                  ±6.0                    18.6    ±1.9      0.661
  ISS (median, IQR)       25                    (17--30)                9       (4--10)   \<0.001

Data are presented as means ± SD, median (IQR), or *n* (%). HTN, hypertension; DM, diabetic mellitus; CVA, cerebral vascular accident; CAD, coronary artery disease; CHF, congestive heart failure; ESRD, end-stage renal disease; SBP, systolic blood pressure; HR, heart rate; RR, respiratory rate; ISS, injury severity scale.

ijerph-15-01769-t005_Table 5

###### 

Variables related to mortality of the patients in multivariate logistic regression.

  Variables           Odds Ratio   (95% CI)     *p*
  ------------------- ------------ ------------ ---------
  Male                1.72         1.32--2.24   \<0.001
  Age                 1.04         1.03--1.04   \<0.001
  CHF                 2.71         1.24--5.92   0.012
  ESRD                3.69         2.23--6.11   \<0.001
  Temperature (°C)    0.66         0.54--0.80   0.002
  HR (beats/min)      0.99         0.99--0.99   \<0.001
  ISS (median, IQR)   1.17         1.16--1.19   \<0.001

CHF, congestive heart failure; ESRD, end-stage renal disease; HR, heart rate; ISS, injury severity scale.

ijerph-15-01769-t006_Table 6

###### 

Comparison of outcomes between study groups before and after propensity score matching.

  Varibles                 Before   After                                                                                                                    
  ------------------------ -------- --------- ------ --------- ----- -------------- ----------- --------- -------- --------- -------- ------- -------------- -------
  Sex, *n* (%)                                                                                                                                               1.000
  Male                     260      (64.8)    7455   (55.8)    1.5   (1.19--1.80)   *\<0.001*   258       (64.7)   258       (64.7)   1.0     (0.75--1.34)   
  Female                   141      (35.2)    5913   (44.2)    0.7   (0.56--0.84)   *\<0.001*   141       (35.3)   141       (35.3)   1.0     (0.75--1.34)   
  Age (years)              53.3     ±19.0     54.3   ±19.4     ---   *0.293*        53.2        ±19.0     53.1     ±19.2     ---      0.969                  
  Comorbidity, *n* (%)                                                                                                                                       
  HTN                      99       (24.7)    3972   (29.7)    0.8   (0.62--0.98)   *0.030*     98        (24.6)   98        (24.6)   1.0     (0.72--1.38)   1.000
  DM                       59       (14.7)    2119   (15.9)    0.9   (0.69--1.21)   *0.579*     57        (14.3)   57        (14.3)   1.0     (0.67--1.49)   1.000
  CVA                      13       (3.2)     589    (4.4)     0.7   (0.42--1.27)   *0.270*     13        (3.3)    13        (3.3)    1.0     (0.46--2.19)   1.000
  CAD                      16       (4.0)     554    (4.1)     1.0   (0.58--1.60)   *0.901*     15        (3.8)    15        (3.8)    1.0     (0.48--2.07)   1.000
  CHF                      5        (1.2)     125    (0.9)     1.3   (0.54--3.29)   *0.594*     5         (1.3)    5         (1.3)    1.0     (0.29--3.48)   1.000
  ESRD                     11       (2.7)     288    (2.2)     1.3   (0.70--2.36)   *0.484*     11        (2.8)    11        (2.8)    1.0     (0.43--2.33)   1.000
  ISS (median, IQR)        10       (5--20)   9      (4--10)   ---   *\<0.001*      10          (5--20)   10       (5--20)   ---      0.950                  
  Mortality, *n* (%)       54       (13.5)    307    (2.3)     6.6   (4.86--9.01)   *\<0.001*   52        (13.0)   37        (9.3)    1.5     (0.94--2.29)   0.115
  LOS in hospital (days)   12.4     ±12.9     10.1   ±10.8     ---   *0.001*        12.4        ±12.9     12.8     ±13.7     ---      0.662                  
  ICU admission, *n* (%)   175      (43.6)    2858   (21.4)    2.8   (2.33--3.48)   *\<0.001*   173       (43.4)   159       (39.8)   1.2     (0.87--1.53)   0.350
  PT (seconds)             11.7     ±4.7      10.9   ±2.6      ---   *\<0.001*      11.2        ±2.9      11.3     ±9.6      ---      0.812                  
  aPTT (seconds)           29.6     ±12.0     27.3   ±4.4      ---   *\<0.001*      28.3        ±9.6      27.6     ±5.0      ---      0.145                  

Data are presented as means ± SD, median (IQR), or *n* (%). HTN, hypertension; DM, diabetic mellitus; CVA, cerebral vascular accident; CAD, coronary artery disease; CHF, congestive heart failure; ESRD, end-stage renal disease; ISS, injury severity scale; LOS, length of stay; ICU, intensive care unit; PT, prothrombin time; aPTT, activated partial thromboplastic time.
